On April 30, the PMDA held the “PMDA-ATC Safety Reporting System of Clinical Trial Webinar 2025 for NPRA, Malaysia”.
The webinar’s theme was Safety Reporting System of Clinical Trial. A PMDA staff member from the Office of Review Management shared information on the Japanese safety case report system, management of safety information and PMDA’s experiences with 20 National Pharmaceutical Regulatory Agency (NPRA) regulators engaging in Safety Monitoring.
The PMDA continues to collaborate with NPRA in capacity building.
See attached program[147 KB]
Back
Back
-
Regulations & Services of PMDAInformation about Approved Products in JapanSafety InformationAdvanced Efforts
-
Information for approved products in JapanSafety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnosticsInformation for approved products in JapanRegulatory science
-
Regulations and services of PMDAInformation for approved products in JapanProcedures in JapanAdvanced efforts
Back
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Reviews and Related ServicesRegulatory ProceduresPost-marketing Safety Measures
-
Reviews and Related ServicesPost-marketing Safety Measures
- Home
- Events and Symposia
- Report of the PMDA-ATC Safety Reporting System of Clinical Trial Webinar 2025 for NPRA, Malaysia
Events and Symposia